Additionally, IDEXX is poised to launch the US Catalyst Pancreatic Lipase test in September 2024, further expanding its diagnostic offerings. These product developments are viewed as incremental ...

Oct 31 (Reuters) - IDEXX Laboratories (IDXX.O), opens new tab trimmed its annual revenue forecast for the third time on Thursday, as the animal health diagnostic equipment maker sees fewer visits ...

IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets.

Idexx Laboratories primarily develops ... Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology ...

The renowned medical device company has a market capitalization of $9.18 billion. IDEXX has an earnings yield of 2.49%, which ...